Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019)
Theravance Biopharma (TBPH) reported Change in Receivables of -$86000.0 for Q4 2019, up 96.42% year-over-year from -$43783.1 in Q4 2018, and up 40.69% quarter-over-quarter from -$145000.0 in Q3 2019.
Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019) Analysis & Trends
Theravance Biopharma (TBPH) has 7 years of Change in Receivables data on file, last reported at -$86000.0 in Q4 2019.
- Change in Receivables for Q4 2019 came in at -$86000.0, up 96.42% year-over-year; the trailing twelve-month figure through Dec 2019 was -$620000.0 (up 62.03% YoY), and the FY2019 annual result was -$620000.0, up 62.03% from the prior year.
- Change in Receivables advanced to -$86000.0 in Q4 2019 per TBPH's latest filing, from -$145000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.5 million in Q2 2018 and troughed at -$2.4 million in Q4 2018.
- A 5-year average of -$14450.0 and a median of $45500.0 in 2015 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2016 and 2018: Change in Receivables slumped 4368.18% in 2016, then soared 1192.92% in 2018.
- A 5-year view of Change in Receivables shows it stood at $1.1 million in 2015, then plunged by 119.93% to -$227000.0 in 2016, then soared by 398.24% to $677000.0 in 2017, then slumped by 455.1% to -$2.4 million in 2018, then soared by 96.42% to -$86000.0 in 2019.
- Business Quant data shows TBPH's Change in Receivables at -$86000.0 in Q4 2019, -$145000.0 in Q3 2019, and $118000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Theravance Biopharma | 835.85 Mn | 441.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -86,000.00 |
| Dec 31, 2019 | -86,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Dec 31, 2018 | -2.40 Mn |
| Dec 31, 2018 | -2.40 Mn |
| Sep 30, 2018 | -410,000.00 |
| Sep 30, 2018 | -410,000.00 |
| Jun 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | -280,000.00 |
| Mar 31, 2018 | -280,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Sep 30, 2017 | 230,000.00 |
| Sep 30, 2017 | 230,000.00 |